-
ALS patient walking, showing improvement after stem cell treatment
FOX News Detroit’s Deena Centofanti speaks with NSI-566/ALS Principal Investigator Eva Feldman, MD, PhD, and Phase I patient, Ted Harada, in a “Health Works” feature on Neuralstem’s “landmark study” with collaborators at the University of Michigan and Emory University, on the eve of the Phase II trial.
Select media coverage in this website is provided for the information and convenience of the public, and is not intended to be all-encompassing nor an endorsement of the specific stories or media outlets.